Entering regulatory writing
Regulatory writing asks for experience that is hard to get without already holding the job. Newcomers reach it through adjacent roles such as clinical research, quality control and editing, bring what a previous role taught them, meet what employers look for, learn the field on their own, find a first post through people, and spend their first years in training, in self-directed learning and on progressively more advanced documents.
Why experience is hard to get without the job
Breaking into regulatory writing is difficult, though not impossible. In the view of one owner of a small medical writing company, medical communications is easier to enter after a doctorate and a postdoctoral post, because agencies, though not easy to get into, will employ someone who has already written manuscripts during a research career, whereas regulatory writing is hard to get experience in without already holding the job. Some small medical writing companies, hers and Trilogy in Germany among them, do employ regulatory writers with no experience, but when she advertises a senior post she looks for at least three years of regulatory writing experience, and manuscript writing does not count towards it.
In 2017, by one writer's account, the direct route into a regulatory writing role at a pharmaceutical, biotechnology or contract research company, without regulatory or pharmaceutical training, was probably the hardest, because it put the burden of training on the employer, so many employers preferred not to hire regulatory writers without experience. Companies willing to train new writers existed in both pharma and contract research, but most did not advertise directly for writers without experience. Entry-level posts did exist for someone with the right aptitude who works well in a team and is serious about the career, when the match between employee and employer was right.
In 2014, in one consultant's view, most big pharmaceutical companies were reluctant to hire people who need to be trained, because time is money. Self-training and certificates or degrees are clearly a plus, but hands-on experience is still the ticket to employment, so the first step is finding a company willing to provide training and experience. Contract research organisations are a great place to look, but pharmaceutical companies, the sponsors of clinical investigations, should not be ruled out, because some leaders are willing to spend the extra time now to develop the perfect long-term employee.
In 2014 a recruiter, a pharmaceutical company employee and a contract research organisation employee tended to agree that the best and easiest start is an entry-level position, advancing with competence and experience. When starting out, being hired usually comes down to a hiring manager taking a chance on a new regulatory writer who shows promise.
The route into regulatory writing is less clearly defined than traditional scientific careers, and newcomers are often unsure where to begin or which competencies to build.
Roles that lead into regulatory writing
In 2017, by one writer's account, most current regulatory writers had probably come by a rarely mentioned route: a medical writing or regulatory affairs job in a pharmaceutical or biotechnology company or a contract research organisation, where experience with the team guiding a drug through its regulations is often the best teacher; many other industry positions that expose employees to project-team clinical development can also lead to regulatory and medical writing careers. Another route runs sideways from clinical research: one writer moved from clinical research associate, visiting doctors and checking trial data, to project manager and then into writing, which she calls a good way into the regulatory field and the way a lot of people have got into regulatory writing. In 2015, by one experienced writer's account, the majority of experienced regulatory writers had started in a related field, at the bottom, and worked their way up into regulatory writing.
Working at a contract research organisation or a sponsor in another clinical research role is a big advantage: a data manager or clinical research associate has some knowledge of clinical research, which could help in finding a writing role inside the same company or elsewhere. One regulatory writer of more than ten years entered this way, from biomedical research through a clinical research associate role. Some roles in a hospital's clinical trial unit carry a lot of clinical research training too, which helps tremendously when writing a protocol, for example. Non-profit organisations supporting investigator-initiated trials offer a narrower range of documents, such as protocols, probably with some medical communication work attached, and are a great entry door into the field. Someone inside a pharmaceutical or biotechnology company but outside clinical development, where most regulatory writing happens, should look for chances to work with a drug development team: get in touch with people working in development in a therapeutic area they know, talk about getting involved, and add it to their career development plan. This takes perseverance and motivation, and support can come as long as the main job's expectations continue to be met.
Medical communication experience is an advantage. It supplies medical-writing skill and an understanding of the service-provider mentality and its expectations, and anyone who has written a manuscript from a clinical study report has already digested a regulatory document. Hybrid roles are another option: a small pharmaceutical company may not staff separate medical communication and regulatory writers, so one writer does both, and a writer can begin with manuscripts for a client or employer and start on regulatory documents later.
Reviewing and editing regulatory documents is a way into writing them. Any document going to a health authority should be quality controlled, which people do against a checklist and by checking internal consistency, and doing that work brings close contact with regulatory documents. Many writers learn the trade by performing quality control reviews of documents written by others, which helps a new writer learn the variation between document types and the styles and presentation conventions of scientific writing. For someone with the necessary skills, starting as a dedicated quality-control reviewer is one way into medical writing, and it gives familiarity with clinical documents, style guides and conventions. For someone whose ultimate goal is regulatory writing, starting as a quality-control reviewer or editor provides a lot of the experience and skills a medical writer needs. For someone with a strong science background but little applicable writing experience, the recommended start is editing regulatory documents, also in an entry-level post. Supporting senior writers with routine tasks such as formatting tables also helps, because it shows both the documents and the writing process, as does, ideally, shadowing a regulatory writer and attending some of their meetings.
Editors see a wide variety of documents, indications and writing styles: in the clinical regulatory environment, typically protocols and amendments, investigator's brochures, clinical study reports and the other documents that are the backbone of research and development, and over time an editor may get to review submission summary documents, the more complex compilations of the entire development story. Reaching that level before seeking the chance to use editing skills for writing is worth trying, though not necessary. In time, an editor should also seek chances to contribute to the actual writing: hands-on experience helps long-term career development, and an appreciation of the writer's perspective can also improve editing.
While gaining editing or writing experience, a writer should keep a spreadsheet listing every document type worked on, the sponsor's name, the indication and their role as a contributor, which comes in handy later, for example when writing a résumé.
Although the industry tends to think of regulatory writers as the people who write the clinical documents, some prefer to focus on other parts of an application: writers focusing on chemistry, manufacturing and controls documents, for example, often have a strong background in chemistry and analytical methods.
What a previous role carries over
The clinical research associate is the missing link between a trial site and the trial's data. Trials are usually run at hospitals, where study personnel have access to medical records holding sensitive identifying information such as names and addresses. Site staff follow the protocol and collect additional clinical data, which is critical for evaluating the drug's safety and efficacy and has to leave the hospital anonymised; the site enters it into a database through a case report form. Someone has to confirm that what was typed in is correct, and that is the associate, who travels to sites and checks both whether the site followed the protocol and whether the data were entered correctly.
The role gives a future writer the study site's perspective on the protocol: why documenting particular things matters, and where site staff look when they need information. It also allows input while a study is being set up, beyond the protocol itself, and better data collection, because the associate knows which data will end up in the database. It supplies an integrated view of the stakeholders and vendors involved in conduct, since the associate controls and manages them. Even without site visits, administrative work at a sponsor allows a deep reading of trial documentation and shows communication best practice inside the industry.
The role's advantages for a future writer are knowledge of trial set-up, an overview of the pharmaceutical industry, familiarity with clinical trial documentation, psychological and teamwork skills learned in depth, flexibility and the ability to work under strong pressure, as at a database lock, and close contact with the running trial and the regulations behind it. Having been a scientist also prepares a writer, through trained analytical capacity, attention to detail, a great deal of scientific writing, experience presenting data at conferences, the resilience a doctorate demands, the habit of continuous learning, and working independently and in an organised way.
Three writers who came to regulatory writing from experimental research, pharmacy practice, computational research, and teaching and medical communication grouped the skills they found most transferable into soft skills, technical skills and core knowledge.
Experimental research gave one of them self-management and project management: managing time, setting priorities and working independently, and handling several project timelines with the flexibility to adjust when research direction shifts or clinical sites are delayed, with resources reassessed as a project develops. Pharmacy practice gave another the leadership that coordinating several functional areas, running meetings and leading presentations calls for. Computational research, teaching and medical communication gave the third process proficiency, meaning running several projects concurrently with a process-driven approach, proficiency in different software and a readiness to troubleshoot and test it as the work grows more dependent on technology, and scientific communication: pitching the detail to the intended audience, modelling scientific thinking while keeping the audience engaged, and using evidence to build a coherent story that supports the conclusions, as a clinical study report does. Pharmacy practice also supplied core knowledge: real-world experience in several therapeutic areas, which built knowledge of disease states that is especially helpful for clinical regulatory documents, and practice in collaborating with multidisciplinary teams.
What employers look for in a regulatory writer
A regulatory writer needs three skills that every medical writer needs: presenting complex scientific information clearly and logically to a particular audience, which for a regulatory writer means distilling large amounts of data into documents for the authorities; knowing the ethical standards and regulatory guidelines, and the formats different documents need, and keeping up with them; and coordinating the planning, preparation, review and finalisation of documents. The first is why a life-science degree and a doctorate are usual. Coordination and guideline knowledge weigh more heavily in regulatory work than in medical communication, because the standards applied to regulatory documents are stronger and the documents have to move quickly. A regulatory writer also needs, even more than other medical writers, to be comfortable communicating with people from a wide range of backgrounds, to be a team player, to be organised and able to organise others, and to manage time and plan well, since the writer coordinates content from many experts. In a pharmaceutical company those experts form large interdisciplinary teams of clinicians, statisticians, study managers, pharmacologists and pharmacovigilance experts.
Aspiring writers come from backgrounds such as biology, pharmacy and medicine, and a life-science degree helps with terminology, mechanisms of action and the development process, but it is by no means mandatory. Successful writers are distinguished not by their degree but by their commitment to mastering the principles of regulatory documentation and their ability to communicate data accurately, ethically and clearly. Personal qualities are needed too: critical and analytical thinking, ethical integrity and meticulous attention to detail are often hard to learn through training alone, and together with resilience they underpin success.
In a recruiter's view in 2014, a science background helps, but the keys to a first project or job are enthusiasm, sincerity, positivity and networking. Key competencies to develop or to highlight include attention to detail, teamwork, preparation, cooperation, professionalism, independent achievement, ambition, being driven by deadlines, initiative, communication expertise, quality of product, orientation to results, and consistency.
Learning the field before the first job
A good place to begin is the drug development process and the regulations and guidelines that govern it and underlie its documents. Someone not ready to enrol in an academic programme can gain a basic understanding of the concepts of regulatory writing in other ways, and should go on researching and learning independently. Regulatory writers also work in regulated areas beyond pharmaceuticals, such as biologics, blood products and medical devices, where the regulations vary according to the agency that will review the product, so the research has to follow the agency.
In the advice of one writer whose career has been mostly in the pharmaceutical industry, the first requirement for an experienced medical writer from another area of health care with no industry background is understanding the industry as a whole: what it is, how and why it came into being, its purpose and how it operates, including the entire development process from the bench and animal studies through phase 0 to 4 trials to mass marketing, even for someone who will only ever work on clinical study documents. The industry must also be understood as a business, because making money is the companies' top priority: nearly every major decision by upper management turns on profit and loss, and a prospective employee or vendor has to accept that philosophy. The next step is to read the regulations in the searchable online Code of Federal Regulations and on the FDA's websites, with their new and revised regulations, guidance, commentaries and example documents; to download the annotated ICH outlines of documents such as a protocol or a clinical study report; and to read the new drug application submission information, including the structure and contents of the Common Technical Document, which matters all the more for someone aiming at regulatory writing. Guidance from the FDA, the EMA and ICH is published online and can simply be read, and the FDA has also posted many videos on YouTube, and one of its departments offers many training resources. A solid grasp of the clinical trial lifecycle and the regulatory environment is invaluable, and familiarity with ICH E3 and E6 gives a foundation for understanding how data are generated and reported; in two writers' experience, starting with the trial phases and the types, structure and relevance of regulatory documents can make early experiences more manageable and help with the first learning curve.
Reading samples of the documents medical writers generally produce is another important step, among them investigational new drug reports; preclinical and clinical study protocols; investigator's brochures; full and abbreviated clinical study reports; informed consent forms; interim, toxicology, pharmacology and pharmacokinetic reports; risk-management plans; briefing documents for FDA meetings; the many Common Technical Document summaries; product labelling; responses to questions from the European Medicines Agency or the FDA; and advisory board slides and meeting summaries. In 2025 real regulatory documents were publicly accessible, so protocols and clinical study reports could be studied directly, for example through Health Canada.
Regulatory medical writing is the development of the clinical documents that follow a product's life cycle from entry into trials through marketing authorisation into post-marketing studies, all of them sent to health authorities for assessment, so knowledge of clinical research is fundamental to it. In 2018 the many free online resources for that knowledge included the University of California, San Diego's drug development programme on Coursera, which works through what has to be considered at each trial phase, and Johns Hopkins University's Coursera course on the design and interpretation of clinical trials; one entrant recommends reading next the ICH guidelines on good clinical practice (E6), general considerations for clinical trials (E8) and the structure and content of clinical study reports (E3). The FDA's Small Business and Industry Assistance education events were mostly free, could be attended in person or online and had their recordings posted afterwards, and the same entrant received a certificate of attendance from one.
Aspiring regulatory writers leaving college have several options for further education, among them formal graduate programmes in medical or scientific writing and education programmes from professional organisations such as AMWA. Free good clinical practice training is available, and the certificate it leads to is very important and can be added to a CV. Training and mentoring in regulatory writing are also available. One small company owner suggests, with some hesitation, that for a newcomer who can afford it, EMWA training in regulatory writing could help impress a potential employer. Courses recommended by three writers who entered regulatory writing include the National Institutes of Health's Introduction to the Principles and Practice of Clinical Research, the North Carolina Regulatory Affairs Forum's Regulatory Affairs Certification Preparation Program, and Eli Lilly's certificate programme Making Medicines: The Process of Drug Development. Hands-on experience helps too: serving on an institutional review board taught one of them local and international regulations, good clinical practice among them, and the ethical principles of clinical research, and had her reviewing protocols and investigator's brochures, and an internship at GlaxoSmithKline in global medical sciences and clinical pharmacology had another compiling data and writing manuscripts, abstracts and presentations from clinical study reports and investigator's brochures.
For someone already working in support of drug development who is considering the switch, a 2008 guide to getting started stresses making contacts and networking, gives practical advice on exploring the career's possibilities and pursuing formal and informal training, and holds that a portfolio of sample articles and presentations is important. It calls the career challenging, dynamic and rewarding, offering a variety of opportunities with companies as well as flexibility for the freelance writer.
Finding the first role through people
A newcomer's network is very important for getting a first role, so they should talk to everybody in it. The conversation should not be forced: asking people what they do and letting them talk shows what different employers are like and which roles exist. The network can be extended, since a father-in-law may know someone at a pharmaceutical company, and in one writer's experience opportunities arise in unexpected places, such as a conversation at a child's birthday party. Joining local and national chapters of associations such as AMWA offers relationships with others in the field, learning from their experience, training recommendations and conferences. Networking is imperative, whether through social media or at the annual conferences and other meetings of professional organisations such as AMWA, the Board of Editors in the Life Sciences, the Regulatory Affairs Professionals Society, DIA and the Society for Technical Communication.
One experienced writer urges a newcomer to join the Drug Information Association, whose meetings teach a great deal about the industry, and to go to its annual meeting if the budget permits, attending the large seminars, the breakout meetings, the meals and the receptions, because in her view meeting people in the industry is critical, and watching and listening to them shows whether one identifies with them enough to want to be around them every day; a newcomer should be quite certain that regulatory writing for industry is the niche they really want. She also advises joining the Regulatory Affairs Professional Society for at least a few years if the budget permits, for its meetings and educational programmes, though its educational certificate is not specific to regulatory writing. In her opinion, a full-time industry job for several years before going freelance is the best way to become intimately familiar with the industry.
In one entrant's view in 2018, the one answer to having no experience is networking, which is not meeting people to beg for a job or to impress a future boss, but taking an interest in the people one meets, listening to their stories, and asking what they need and how to help; what a large company is really like inside stays unknown without an insider. It works through LinkedIn and its groups, an email complimenting someone's blog or writing, career fairs and local events for personal contact, and membership of a professional association such as EMWA to make the reach targeted. It takes time: for this entrant, most contacts took three to six months to warm up, some never did, and the offer of a position came a little over a year and more than two hundred applications after the first one.
A recruiter advised in 2014 that a newcomer can contact recruiters and send a CV directly to potential clients and employers, and that the best strategy at the start is to approach hiring managers and network directly as often as possible. A passionate, detailed cover letter explaining one's interest and enthusiasm for the field is also recommended.
In one case, a new freelance who had networked in Vienna with the owner and co-founder of a company, and had told him, probably more than once, that she wanted to get into regulatory writing and was looking for an opportunity, was later asked by him to work as a consultant on FDA regulatory submissions for medical devices and combination products. In the following six to seven months she learned FDA regulatory requirements, writing quality management system documents, interacting with clients, working remotely in a team spread across every time zone, the differences between FDA requirements and the EU MDR, and project management. She had often heard regulatory writing called dry, and found it challenging and interesting: coming from basic science, she was learning about the mechanisms that control a product's safety and efficacy, how the life cycle of a drug or device is controlled while the latest research reaches end users without too much delay, and how clinical trials are conducted.
The first years in the job
The documents most regulatory writers begin with may include clinical trial protocols, subject safety narratives, which describe an adverse event in a specific subject, and informed consent forms, and the writer might then advance to helping write a clinical trial report or an investigator's brochure. The most advanced regulatory writers are assigned the summaries for investigational and marketing applications, in which data from multiple studies are often integrated, and other documents such as overviews, introductory documents and sometimes briefing packages for meetings with the FDA.
One pharmaceutical company's training course for new writers follows the AMWA Recommended Training Outline in three areas: core knowledge and skills, documents, and soft skills. For core knowledge and skills, one of its writers recommends the AMWA Essential Skills Certificate Program, which also shows a commitment to professional development; technical aptitude, which raises productivity and efficiency, covers Word, a helpful authoring tool now that regulatory documents are primarily digital, a collaborative authoring platform such as SharePoint that lets several writers work on a document at once, table, listing and figure tools, and a quality control tool, which is essential for making sure a document is ready for submission. For documents, a rotational programme gave hands-on work and shadowing, covering how documents are built, the quality control group and consensus meetings, before the new writers eventually became lead authors. For soft skills, developing self-management and people skills strengthens a writer's ability to work collaboratively, remotely included, and strong people skills are critical to leading the meetings and managing the team that build a cohesive document.
Much of a new writer's development comes from self-directed learning and active engagement with projects. Curiosity needs balance: before a question is asked it should be thought through and investigated, since careful reading, logic, the guidelines or past work resolve many. Completed and ongoing projects, typically stored internally and often with tracked versions and reviewer comments, can be studied in quiet hours for writing styles, workflow and the review process. Staying up to date with the latest changes to the guidelines and requirements for regulatory documents, by regularly checking regulatory agencies' pages or setting alerts, is highly recommended; major updates are infrequent and slow to arrive but can change document requirements significantly, so changes that may affect future projects should be captured. Most learning will come from real projects, where timelines can shift, projects may be delayed or cancelled, clients may have high expectations or urgent demands, and quality, accuracy and timelines have to be balanced while working with statisticians, clinicians, subject matter experts and project managers, each with their own priorities. Repeated exposure to projects gradually builds an intuition for how documents are structured, how language is used and how reviewers give feedback, and over time confidence, efficiency and the ability to anticipate questions or issues, and reviewing past work for what went well, what could be improved and how to apply the lessons is a hallmark of a growing writer.